[1]
Arkblad E., Tulinius M., Kroksmark AK. et al.: A population-based study
of genotypic and phenotypic variability in children with spinal muscular
atrophy. Acta Paediatr., 2009:20, [Epub ahead of print]
[2]
Talbot K.: What’s new in the molecular genetics of spinal muscular
atrophy? Eur. J. Paediatr. Neurol., 1997:5/6, 149.
[3]
Prior T.W.: Spinal muscular atrophy diagnostics. J. Child Neurol.,
2007:22, 952-956.
[4]
Parsons D.W., McAndrew P.E., Iannaccone S.T. et al.: Intragenic telSMN
mutations: frequency distribution, evidence of founder effect and modification
of the spinal muscular atrophy phenotype by cenSMN copy
number. Am. Hum. Genet., 1998:63, 1712-1723.
[5]
Kotani T., Sutomo R., Sasongko T.H. et al.: A novel mutation at the N-terminal
of SMN Tudor domain inhibits its interaction with target proteins.
J. Neurol., 2007:254, 624-630.
[6]
Oskoui M., Levy G., Garland C.J. et al.: The changing natural history of
spinal muscular atrophy type 1. Neurology, 2007:69, 1931-1936.
[7]
Bach J.R., Saltstein K., Sinquee D. et al.: Long-term survival in Werdnig-
Hoffmann disease. Am. J. Phys. Med. Rehabil., 2007:86, 339-45 quiz
346-348, 379.
[8]
Gergont A., Kaciński M., Steczkowska-Klucznik M.: Postępy w diagnostyce
rdzeniowego zaniku mięśni. Przegl. Lek., 2001:58, 989-991.
[9]
Lee J.S., Hwang J.S., Ryu K.H. et al.: Mitochondrial respiratory complex I
deficiency simulating spinal muscular atrophy. Pediatr. Neurol., 2007:36,
45-47.
[10]
Anagnostou E., Miller S.P., Guiot M.C. et al.: Type I spinal muscular
atrophy can mimic sensory-motor axonal neuropathy. J. Child Neurol.,
2005:20, 147-150.
[11]
Renault F.: The role of electrodiagnostic studies in the diagnosis of hypotonia
in infancy. Rev. Med. Liege, 2004:59, 190-197.
[12]
Barisić N., Sertić J., Billi C. et al.: Molecular analysis and electromyoneurographic
abnormalities in Croatian children with proximal spinal
muscular atrophies. Clin. Chem. Lab. Med., 1998:36, 667-669.
[13]
Imai T., Saito M., Matsumoto H. et al.: Correlation between the M and
F wave characteristics and the innervated muscle strength in spinal
muscular atrophy. Brain Dev., 1998:20, 44-46.
[14]
Renault F., Raimbault J., Praud J.P. et al.: Electromyographic study of
50 cases of Werdnig-Hoffmann disease. Rev. Electroencephalogr. Neurophysiol.
Clin., 1983:13, 301-305.
[15]
Hausmanowa-Petrusewicz I., Karwańska A.: Electromyographic findings
in different forms of infantile and juvenile proximal spinal muscular
atrophy. Muscle Nerve, 1986:9, 37-46.
[16]
Emeryk-Szajewska B., Kopeć J., Karwańska A.: The reorganisation of
motor units in different motor neuron disorders. Electromyogr. Clin. Neurophysiol.,
2003:43, 23-31.
[17]
Rowińska-Marcińska K., Ryniewicz B., Hausmanowa-Petrusewicz I. et
al.: Diagnostic value of satellite potentials in clinical EMG. Electromyogr.
Clin. Neurophysiol., 1997:37, 483-489.
[18]
Hausmanowa-Petrusewicz I.: Electrophysiological findings in childhood
spinal muscular atrophies. Rev. Neurol. (Paris), 1988:144, 716-720.
[19]
Tsai L.K., Tsai M.S., Ting C.H. et al.: Multiple therapeutic effects of valproic
acid in spinal muscular atrophy model mice. J. Mol. Med., 2008:86,
1243-1254.
[20]
Bosboom W.M., Vrancken A.F., van den Berg L.H. et al.: Drug treatment
for spinal muscular atrophy types II and III. Cochrane Database Syst.
Rev., 2009:21, CD006282.
[21]
Bosboom W.M., Vrancken A.F., van den Berg L.H. et al.: Drug treatment
for spinal muscular atrophy type I. Cochrane Database Syst. Rev.,
2009:21, CD006281.
[22]
Alias L., Barceló M.J., Gich I. et al.: Evidence of a segregation ratio
distortion of SMN1 alleles in spinal muscular atrophy. Eur. J. Hum.
Genet., 2007:15, 1090-1093.
Scholar Google
PubMed